Condition category
Mental and Behavioural Disorders
Date applied
01/08/2007
Date assigned
05/09/2007
Last edited
21/03/2013
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Prof Hans-Christoph Steinhausen

ORCID ID

Contact details

Department of Child and Adolescent Psychiatry
University of Zurich
Neumuensterallee 9
POB
Zurich
CH-8032
Switzerland
+41 4349 92730
hans-christoph.steinhausen@kjpd.uzh.ch

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Acronym

Study hypothesis

1. The agreement between pre-clinical assessment (DAWBA based) and blind clinical assessment is incomplete.
2. The disclosure of pre-clinical assessment diagnoses will have an effect on clinical diagnoses including comorbidities.
3. Parents and adolescents will display acceptance and satisfaction with pre-clinical assessment based on the DAWBA.

Ethics approval

The trial was approved by the Ethical Committee of the Canton of Zurich, Specialized Subcommittee Psychiatry, Neurology, Neurosurgery, on the 1st June 2007.

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Diagnostic

Patient information sheet

Condition

Childhood psychiatric disorders

Intervention

The provision of diagnostic information based on the DAWBA to the clinicians treating the intervention group. The control group will undergo a normal clinical assessment. The diagnostic information will be gathered from parents, adolescents above the age of 11 years, and teachers.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

The level of agreement between the pre-clinical assessment and the clinical assessment.

Secondary outcome measures

Clinical routine ratings by the clinicians and parents.

Overall trial start date

01/09/2007

Overall trial end date

31/08/2008

Reason abandoned

Eligibility

Participant inclusion criteria

The trial will include referrals from four outpatient clinics of the service. Patients will be aged 5-18 years.

Participant type

Patient

Age group

Child

Gender

Both

Target number of participants

500

Participant exclusion criteria

Children of parents with insufficient unterstanding of German and emergency referrals will be excluded.

Recruitment start date

01/09/2007

Recruitment end date

31/08/2008

Locations

Countries of recruitment

Switzerland

Trial participating centre

Department of Child and Adolescent Psychiatry
Zurich
CH-8032
Switzerland

Sponsor information

Organisation

University of Zurich (Switzerland)

Sponsor details

Neumuensterallee 9
Postfach
Zurich
CH-8032
Switzerland

Sponsor type

University/education

Website

http://www.uzh.ch/about_en.html

Funders

Funder type

University/education

Funder name

Research budget of the Department of Child and Adolescent Psychiatry, University of Zurich (Switzerland)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

1. 2012 results in http://www.ncbi.nlm.nih.gov/pubmed/22722664

Publication citations

  1. Results

    Aebi M, Kuhn C, Metzke CW, Stringaris A, Goodman R, Steinhausen HC, The use of the development and well-being assessment (DAWBA) in clinical practice: a randomized trial., Eur Child Adolesc Psychiatry, 2012, 21, 10, 559-567, doi: 10.1007/s00787-012-0293-6.

Additional files

Editorial Notes